A new validated RP-HPLC method for determination of rosuvastatin calcium in bulk and pharmaceutical dosage form

Der Pharmacia Lettre

Volumn 3, Issue 3, 2011, Pages 350-356

  Donthula, Sandhya ^a   Kumar, Meriga Kiran ^a   Teja, G Shiva ^a   Kumar, Y Mohan ^a   Krishna, J Yasodha ^b   Ramesh, D ^b  

^a MRR College of B Pharmacy   (India)

^b Sri Sarada College of Pharmacy   (India)

Author keywords

Crestor; Rosuvastatin; RP HPLC

Indexed keywords

ROSUVASTATIN;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); DRUG DETERMINATION; INSTRUMENT VALIDATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; RELIABILITY; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; TABLET;

EID: 79961054852     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Desager JP, Hormans Y. Clin Pharmcokinet. 1996; 31: 348-371.
2. www.nlm.nih.gov/medlineplus/druginfo/uspdi.
3. Available from: http://www.rxlist.com/cgi/generic/cozaar.htm.
4. Burnham TH. HMG-CoA reductase inhibitors. In: ed. Drug Facts and Comparisons. Louis: Facts and Comparisons, Inc 2002; 536-542a.
5. HO Kaila, MA Ambasana, RS Thakkar, HT Saravaia, AK Shah. International journal of pharmaceutical sciences, 2010; 72(5): 592-598.
6. Development and validation of RP-HPLC method for determination of rosuvastatin in bulk and pharmaceutical dosage form. International journal of pharmaceutical sciences review and research, 2010; 5:1.
7. FDA., 2000. Analytical Procedures and Methods Validation: Chemistry, Manufacturing, and Controls. Federal Register (Notices) 65 (169): 52, 776-777.
8. ICH Q2A., 1995. Guidelines on validation of analytical procedure: Definitions and terminology. Federal Register. 60, 11260.
9. ICH Q2B., 1996. Guidelines on validation of analytical procedure: methodology. Federal Register. 60, 27464.